IL134046A0 - Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide - Google Patents

Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Info

Publication number
IL134046A0
IL134046A0 IL13404698A IL13404698A IL134046A0 IL 134046 A0 IL134046 A0 IL 134046A0 IL 13404698 A IL13404698 A IL 13404698A IL 13404698 A IL13404698 A IL 13404698A IL 134046 A0 IL134046 A0 IL 134046A0
Authority
IL
Israel
Prior art keywords
diguanide
thiazolidinedione
diabetes
treatment
insulin secretagogue
Prior art date
Application number
IL13404698A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL134046A0 publication Critical patent/IL134046A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13404698A 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide IL134046A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002110 WO1999003477A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Publications (1)

Publication Number Publication Date
IL134046A0 true IL134046A0 (en) 2001-04-30

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13404698A IL134046A0 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Country Status (39)

Country Link
EP (1) EP1001783B1 (enEXAMPLES)
JP (2) JP2001510159A (enEXAMPLES)
KR (1) KR100671918B1 (enEXAMPLES)
CN (1) CN1264303A (enEXAMPLES)
AP (1) AP1352A (enEXAMPLES)
AR (1) AR016349A1 (enEXAMPLES)
AT (1) ATE305790T1 (enEXAMPLES)
AU (1) AU8448898A (enEXAMPLES)
BG (1) BG64785B1 (enEXAMPLES)
BR (1) BR9810445A (enEXAMPLES)
CA (1) CA2296653C (enEXAMPLES)
CO (1) CO4940420A1 (enEXAMPLES)
CY (1) CY1105254T1 (enEXAMPLES)
DE (1) DE69831808T2 (enEXAMPLES)
DK (1) DK1001783T3 (enEXAMPLES)
DZ (1) DZ2562A1 (enEXAMPLES)
EA (1) EA003021B1 (enEXAMPLES)
ES (1) ES2251093T3 (enEXAMPLES)
GB (1) GB9715295D0 (enEXAMPLES)
HU (1) HUP0003629A3 (enEXAMPLES)
ID (1) ID24211A (enEXAMPLES)
IL (1) IL134046A0 (enEXAMPLES)
IN (1) IN189275B (enEXAMPLES)
MA (1) MA24607A1 (enEXAMPLES)
MY (1) MY155219A (enEXAMPLES)
NO (1) NO325727B1 (enEXAMPLES)
NZ (2) NZ501164A (enEXAMPLES)
OA (1) OA11279A (enEXAMPLES)
PE (1) PE99599A1 (enEXAMPLES)
PL (2) PL197844B1 (enEXAMPLES)
SA (1) SA98190468B1 (enEXAMPLES)
SI (1) SI1001783T1 (enEXAMPLES)
SK (1) SK285484B6 (enEXAMPLES)
TR (1) TR200000134T2 (enEXAMPLES)
TW (1) TW505516B (enEXAMPLES)
UA (1) UA70303C2 (enEXAMPLES)
UY (1) UY25102A1 (enEXAMPLES)
WO (1) WO1999003477A1 (enEXAMPLES)
ZA (1) ZA986363B (enEXAMPLES)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
PL347634A1 (en) * 1998-11-12 2002-04-22 Smithkline Beecham Plc Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
WO2001035940A2 (en) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
PL362687A1 (en) 2001-01-12 2004-11-02 Sun Pharmaceutical Industries Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
WO2003005995A1 (en) * 2001-07-10 2003-01-23 Aeropharm Technology Incorporated Core formulation comprising pioglitazone hydrochloride and a biguanide
PL376577A1 (pl) 2002-06-17 2006-01-09 Themis Laboratories Private Limited Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
KR20100137023A (ko) * 2002-09-20 2010-12-29 안드렉스 랩스 엘엘씨 약제학적 정제
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
PL1677792T3 (pl) 2003-10-31 2016-05-31 Takeda Pharmaceuticals Co Stały preparat zawierający pioglitazon, glimepiryd i ester polioksyetylenosorbitanu z kwasem tłuszczowym
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
KR102176069B1 (ko) * 2017-10-20 2020-11-09 주식회사 노브메타파마 아연염, 시클로-히스프로 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
FI904414A7 (fi) * 1988-03-08 1990-09-07 Pfizer Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
ATE151634T1 (de) * 1991-08-26 1997-05-15 Upjohn Co Flüssiges nahrungsmittel, das 3- guanidinopropionsäure enthält
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
AU8539298A (en) * 1997-06-18 1999-01-04 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and sulphonylurea

Also Published As

Publication number Publication date
AR016349A1 (es) 2001-07-04
OA11279A (en) 2003-07-31
KR20010021947A (ko) 2001-03-15
UA70303C2 (uk) 2004-10-15
PL338126A1 (en) 2000-09-25
KR100671918B1 (ko) 2007-01-22
NZ511608A (en) 2002-12-20
MA24607A1 (fr) 1999-04-01
SK285484B6 (sk) 2007-02-01
AU8448898A (en) 1999-02-10
BG64785B1 (bg) 2006-04-28
PL198017B1 (pl) 2008-05-30
EP1001783B1 (en) 2005-10-05
EA200000139A1 (ru) 2000-06-26
PE99599A1 (es) 1999-12-18
NO20000228L (no) 2000-01-17
NO325727B1 (no) 2008-07-07
SK592000A3 (en) 2000-09-12
CY1105254T1 (el) 2010-03-03
NO20000228D0 (no) 2000-01-17
ES2251093T3 (es) 2006-04-16
BR9810445A (pt) 2000-09-05
WO1999003477A1 (en) 1999-01-28
ZA986363B (en) 2000-01-17
TR200000134T2 (tr) 2000-09-21
ID24211A (id) 2000-07-13
CA2296653A1 (en) 1999-01-28
AP1352A (en) 2004-12-24
DE69831808T2 (de) 2006-07-06
TW505516B (en) 2002-10-11
DZ2562A1 (fr) 2003-02-15
CA2296653C (en) 2007-10-02
MY155219A (en) 2015-09-30
CO4940420A1 (es) 2000-07-24
JP2001510159A (ja) 2001-07-31
HK1028550A1 (en) 2001-02-23
UY25102A1 (es) 2000-12-29
HUP0003629A3 (en) 2003-04-28
ATE305790T1 (de) 2005-10-15
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
CN1264303A (zh) 2000-08-23
JP2005213273A (ja) 2005-08-11
EP1001783A1 (en) 2000-05-24
SA98190468B1 (ar) 2007-01-20
NZ501164A (en) 2001-06-29
DK1001783T3 (da) 2006-02-06
EA003021B1 (ru) 2002-12-26
HUP0003629A2 (hu) 2001-07-30
BG104135A (en) 2000-10-31
IN189275B (enEXAMPLES) 2003-01-25
GB9715295D0 (en) 1997-09-24
AP2000001733A0 (en) 2000-03-31
DE69831808D1 (de) 2006-02-16

Similar Documents

Publication Publication Date Title
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
IL134046A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
PL342517A1 (en) Methods of treating diabetes employing peptidic insulin analoques
ZA985546B (en) Treatment of insulin resistance.
HUP0003876A3 (en) Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
IL127219A0 (en) The use of insulin sensitivity enhancers for treatment of hyperuricemia and compositions containing insulin sensitivity enhancers for treating the same
AP9901718A0 (en) Treatment of diabetes with rosiglitazone and insulin
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
IL134045A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL133137A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
EP0954324A4 (en) CYCLIC PEPTID VACCINES FOR DIABETES TREATMENT AND PREVENTION
IL133138A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
HK1028551A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
HK1028198A (en) Treatment of diabetes with rosiglitazone and insulin
IL143088A0 (en) A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL94241A0 (en) Diagnosis and treatment of insulin dependent diabetes mellitus
AU8884198A (en) Diagnosis, prevention and treatment of diabetes
GB9618290D0 (en) Treatment of diabetes
IL119526A0 (en) Preparations comprising T cells for prevention or treatment of insulin dependent diabetes mellitus (IDDM)
GB9609897D0 (en) Treatment of diabetes